Novo Nordisk launches limited offer: New patients can start Ozempic or Wegovy for $199 a month

Novo Nordisk is offering a new discount on its GLP-1 drugs Ozempic and Wegovy for a short time. The prices are lower for both new and existing patients. These medicines are very popular for diabetes and weight loss, and many people in the U.S. use them. The company says it wants to make the treatments easier to afford.